Literature DB >> 21379357

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Marc DE Hert, Christoph U Correll, Julio Bobes, Marcelo Cetkovich-Bakmas, Dan Cohen, Itsuo Asai, Johan Detraux, Shiv Gautam, Hans-Jurgen Möller, David M Ndetei, John W Newcomer, Richard Uwakwe, Stefan Leucht.   

Abstract

The lifespan of people with severe mental illness (SMI) is shorter compared to the general population. This excess mortality is mainly due to physical illness. We report prevalence rates of different physical illnesses as well as important individual lifestyle choices, side effects of psychotropic treatment and disparities in health care access, utilization and provision that contribute to these poor physical health outcomes. We searched MEDLINE (1966 - August 2010) combining the MeSH terms of schizophrenia, bipolar disorder and major depressive disorder with the different MeSH terms of general physical disease categories to select pertinent reviews and additional relevant studies through cross-referencing to identify prevalence figures and factors contributing to the excess morbidity and mortality rates. Nutritional and metabolic diseases, cardiovascular diseases, viral diseases, respiratory tract diseases, musculoskeletal diseases, sexual dysfunction, pregnancy complications, stomatognathic diseases, and possibly obesity-related cancers are, compared to the general population, more prevalent among people with SMI. It seems that lifestyle as well as treatment specific factors account for much of the increased risk for most of these physical diseases. Moreover, there is sufficient evidence that people with SMI are less likely to receive standard levels of care for most of these diseases. Lifestyle factors, relatively easy to measure, are barely considered for screening; baseline testing of numerous important physical parameters is insufficiently performed. Besides modifiable lifestyle factors and side effects of psychotropic medications, access to and quality of health care remains to be improved for individuals with SMI.

Entities:  

Keywords:  Physical illness; bipolar disorder; depression; health disparities; psychotropic medication; schizophrenia; severe mental illness

Year:  2011        PMID: 21379357      PMCID: PMC3048500          DOI: 10.1002/j.2051-5545.2011.tb00014.x

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  558 in total

1.  Causes of the excess mortality of schizophrenia.

Authors:  S Brown; H Inskip; B Barraclough
Journal:  Br J Psychiatry       Date:  2000-09       Impact factor: 9.319

2.  Disparities in diabetes care: impact of mental illness.

Authors:  Susan M Frayne; Jewell H Halanych; Donald R Miller; Fei Wang; Hai Lin; Leonard Pogach; Erica J Sharkansky; Terence M Keane; Katherine M Skinner; Craig S Rosen; Dan R Berlowitz
Journal:  Arch Intern Med       Date:  2005 Dec 12-26

3.  Dental conditions in patients with bipolar disorder on long-term lithium maintenance therapy.

Authors:  A H Friedlander; N J Birch
Journal:  Spec Care Dentist       Date:  1990 Sep-Oct

4.  Medical comorbidity in women and men with schizophrenia: a population-based controlled study.

Authors:  Caroline P Carney; Laura Jones; Robert F Woolson
Journal:  J Gen Intern Med       Date:  2006-11       Impact factor: 5.128

5.  The five-site health and risk study of blood-borne infections among persons with severe mental illness.

Authors:  Stanley D Rosenberg; Jeffrey W Swanson; George L Wolford; Fred C Osher; Marvin S Swartz; Susan M Essock; Marian I Butterfield; Bryan J Marsh
Journal:  Psychiatr Serv       Date:  2003-06       Impact factor: 3.084

6.  Prevalence of hepatitis A, hepatitis B, and HIV among hepatitis C-seropositive state hospital patients: results from Oregon State Hospital.

Authors:  Jonathan M Meyer
Journal:  J Clin Psychiatry       Date:  2003-05       Impact factor: 4.384

7.  Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

Authors:  Mauricio Tohen; Eduard Vieta; Joseph Calabrese; Terence A Ketter; Gary Sachs; Charles Bowden; Philip B Mitchell; Franca Centorrino; Richard Risser; Robert W Baker; Angela R Evans; Karin Beymer; Sanjay Dube; Gary D Tollefson; Alan Breier
Journal:  Arch Gen Psychiatry       Date:  2003-11

8.  Long-term changes in weight and plasma lipids during maintenance treatment with ziprasidone.

Authors:  Peter J Weiden; John W Newcomer; Antony D Loebel; Ruoyong Yang; Harold E Lebovitz
Journal:  Neuropsychopharmacology       Date:  2007-07-18       Impact factor: 7.853

9.  Antidepressant-induced weight gain: a comparison study of four medications.

Authors:  M H Fernstrom; D J Kupfer
Journal:  Psychiatry Res       Date:  1988-12       Impact factor: 3.222

Review 10.  Lung cancer: current diagnosis and treatment.

Authors:  Stefan Hammerschmidt; Hubert Wirtz
Journal:  Dtsch Arztebl Int       Date:  2009-12-04       Impact factor: 5.594

View more
  532 in total

1.  Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project.

Authors:  Roman Kotov; Laura Fochtmann; Kaiqiao Li; Marsha Tanenberg-Karant; Eduardo A Constantino; Joan Rubinstein; Greg Perlman; Eva Velthorst; Anne-Kathrin J Fett; Gabrielle Carlson; Evelyn J Bromet
Journal:  Am J Psychiatry       Date:  2017-08-04       Impact factor: 18.112

Review 2.  Frequency and Nature of Medication Errors and Adverse Drug Events in Mental Health Hospitals: a Systematic Review.

Authors:  Ghadah H Alshehri; Richard N Keers; Darren M Ashcroft
Journal:  Drug Saf       Date:  2017-10       Impact factor: 5.606

3.  Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.

Authors:  Marc De Hert; Dan Cohen; Julio Bobes; Marcelo Cetkovich-Bakmas; Stefan Leucht; David M Ndetei; John W Newcomer; Richard Uwakwe; Itsuo Asai; Hans-Jurgen Möller; Shiv Gautam; Johan Detraux; Christoph U Correll
Journal:  World Psychiatry       Date:  2011-06       Impact factor: 49.548

4.  Papers and documents available on the WPA website.

Authors: 
Journal:  World Psychiatry       Date:  2012-02       Impact factor: 49.548

5.  Report on the implementation of the WPA Action Plan 2008-2011.

Authors:  Mario Maj
Journal:  World Psychiatry       Date:  2011-10       Impact factor: 49.548

6.  Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status.

Authors:  Philip D Harvey; Martin Strassnig
Journal:  World Psychiatry       Date:  2012-06       Impact factor: 49.548

7.  Predictors of smoking cessation group treatment engagement among veterans with serious mental illness.

Authors:  Letitia E Travaglini; Lan Li; Clayton H Brown; Melanie E Bennett
Journal:  Addict Behav       Date:  2017-07-10       Impact factor: 3.913

8.  Feasibility and effectiveness of an automated telehealth intervention to improve illness self-management in people with serious psychiatric and medical disorders.

Authors:  Sarah I Pratt; Stephen J Bartels; Kim T Mueser; John A Naslund; Rosemarie Wolfe; Heather S Pixley; Louis Josephson
Journal:  Psychiatr Rehabil J       Date:  2013-12

9.  Schizophrenia--time to commit to policy change.

Authors:  W Wolfgang Fleischhacker; Celso Arango; Paul Arteel; Thomas R E Barnes; William Carpenter; Ken Duckworth; Silvana Galderisi; Lisa Halpern; Martin Knapp; Stephen R Marder; Mary Moller; Norman Sartorius; Peter Woodruff
Journal:  Schizophr Bull       Date:  2014-04       Impact factor: 9.306

10.  Using Electronic Health Records to Enhance a Peer Health Navigator Intervention: A Randomized Pilot Test for Individuals with Serious Mental Illness and Housing Instability.

Authors:  Erin L Kelly; Joel T Braslow; John S Brekke
Journal:  Community Ment Health J       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.